Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001753926-25-000175
Filing Date
2025-02-04
Accepted
2025-02-04 16:43:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 16928
  Complete submission text file 0001753926-25-000175.txt   18765
Mailing Address 203 REDWOOD PARKWAY SUITE 600 REDWOOD CITY CA 94065
Business Address 203 REDWOOD PARKWAY SUITE 600 REDWOOD CITY CA 94065 (650) 832-1626
BIOTRICITY INC. (Subject) CIK: 0001630113 (see all company filings)

EIN.: 472548273 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91546 | Film No.: 25589036
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 3053 FILLMORE ST. SUITE 256 SAN FRANCISCO CA 94123
Business Address 3053 FILLMORE ST. SUITE 256 SAN FRANCISCO CA 94123 415-999-2132
Ionic Ventures, LLC (Filed by) CIK: 0001769419 (see all company filings)

EIN.: 660889836 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A